# Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

> **NCT01857544** · PHASE4 · UNKNOWN · sponsor: **Tennessee Retina** · enrollment: 10 (actual)

## Conditions studied

- Retinal Vein Occlusion

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT01857544
- **Lead sponsor:** Tennessee Retina
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01857544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01857544, "Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01857544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*